Equasens S. A. (EQS) - Total Assets

Latest as of June 2025: €410.92 Million EUR ≈ $480.41 Million USD

Based on the latest financial reports, Equasens S. A. (EQS) holds total assets worth €410.92 Million EUR (≈ $480.41 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Equasens S. A. net assets for net asset value and shareholders' equity analysis.

Equasens S. A. - Total Assets Trend (2004–2024)

This chart illustrates how Equasens S. A.'s total assets have evolved over time, based on quarterly financial data.

Equasens S. A. - Asset Composition Analysis

Current Asset Composition (December 2024)

Equasens S. A.'s total assets of €410.92 Million consist of 30.8% current assets and 69.2% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 4.0%
Accounts Receivable €59.33 Million 14.9%
Inventory €10.33 Million 2.6%
Property, Plant & Equipment €29.91 Million 7.5%
Intangible Assets €45.97 Million 11.6%
Goodwill €103.95 Million 26.1%

Asset Composition Trend (2004–2024)

This chart illustrates how Equasens S. A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see EQS market cap.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Equasens S. A.'s current assets represent 30.8% of total assets in 2024, a decrease from 59.5% in 2004.
  • Cash Position: Cash and equivalents constituted 4.0% of total assets in 2024, down from 34.8% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 30.0% in 2004.
  • Asset Diversification: The largest asset category is goodwill at 26.1% of total assets.

Equasens S. A. Competitors by Total Assets

Key competitors of Equasens S. A. based on total assets are shown below.

Company Country Total Assets
VSee Health, Inc.
NASDAQ:VSEE
USA $18.71 Million
Oakridge International Ltd
AU:OAK
Australia AU$1.61 Million
Pro Medicus Ltd
AU:PME
Australia AU$533.91 Million
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
ARTRYA Ltd
AU:AYA
Australia AU$23.68 Million
Cogstate Ltd
AU:CGS
Australia AU$64.77 Million
Alcidion Group Ltd
AU:ALC
Australia AU$115.63 Million
Oneview Healthcare Plc
AU:ONE
Australia AU$15.49 Million

Equasens S. A. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.29 1.09 1.22
Quick Ratio 1.20 1.00 1.14
Cash Ratio 0.00 0.00 0.00
Working Capital €36.92 Million €11.41 Million €20.70 Million

Equasens S. A. - Advanced Valuation Insights

This section examines the relationship between Equasens S. A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.37
Latest Market Cap to Assets Ratio 1.38
Asset Growth Rate (YoY) 1.0%
Total Assets €398.01 Million
Market Capitalization $549.40 Million USD

Valuation Analysis

Above Book Valuation: The market values Equasens S. A.'s assets above their book value (1.38x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Equasens S. A.'s assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Equasens S. A. (2004–2024)

The table below shows the annual total assets of Equasens S. A. from 2004 to 2024.

Year Total Assets Change
2024-12-31 €398.01 Million
≈ $465.32 Million
+1.01%
2023-12-31 €394.05 Million
≈ $460.68 Million
+12.32%
2022-12-31 €350.81 Million
≈ $410.14 Million
+6.32%
2021-12-31 €329.95 Million
≈ $385.75 Million
+11.55%
2020-12-31 €295.78 Million
≈ $345.79 Million
+14.60%
2019-12-31 €258.10 Million
≈ $301.75 Million
+15.32%
2018-12-31 €223.81 Million
≈ $261.66 Million
+25.62%
2017-12-31 €178.16 Million
≈ $208.29 Million
+18.22%
2016-12-31 €150.70 Million
≈ $176.18 Million
+21.55%
2015-12-31 €123.98 Million
≈ $144.95 Million
+9.18%
2014-12-31 €113.55 Million
≈ $132.75 Million
+3.79%
2013-12-31 €109.41 Million
≈ $127.91 Million
+7.36%
2012-12-31 €101.91 Million
≈ $119.14 Million
+12.15%
2011-12-31 €90.86 Million
≈ $106.23 Million
+6.98%
2010-12-31 €84.94 Million
≈ $99.30 Million
+5.86%
2009-12-31 €80.23 Million
≈ $93.80 Million
+2.13%
2008-12-31 €78.56 Million
≈ $91.84 Million
+12.20%
2007-12-31 €70.02 Million
≈ $81.86 Million
+4.89%
2006-12-31 €66.75 Million
≈ $78.04 Million
+19.92%
2005-12-31 €55.66 Million
≈ $65.08 Million
+8.82%
2004-12-31 €51.15 Million
≈ $59.80 Million
--

About Equasens S. A.

PA:EQS France Health Information Services
Market Cap
$659.00 Million
€563.68 Million EUR
Market Cap Rank
#12038 Global
#179 in France
Share Price
€37.50
Change (1 day)
-4.34%
52-Week Range
€33.90 - €53.50
All Time High
€115.42
About

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare p… Read more